NMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nomura Holdings Inc (NMR) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are neutral, the options data suggests low trading sentiment, and the financial performance shows declining revenue and net income. While gross margin has improved, this alone does not outweigh the negative trends. There are no significant positive catalysts or recent news to drive the stock higher in the short term. A hold is recommended until clearer positive signals emerge.
The MACD is below 0 and negatively contracting, indicating a bearish trend. RSI is neutral at 49.48, and moving averages are converging, showing no clear direction. The stock is trading near its pivot point (9.248), with resistance at 9.515 and support at 8.981, suggesting limited upside potential in the short term.
Gross margin increased by 14.03% YoY, showing some operational efficiency improvement.
Revenue, net income, and EPS all declined YoY in the latest quarter (2026/Q2). No recent news or significant trading trends from hedge funds, insiders, or Congress. Analysts removed a related company from the APAC Conviction List, which may indirectly affect sentiment.
In 2026/Q2, revenue dropped by -5.41% YoY to $7.88 billion, net income fell by -5.35% YoY to $624.5 million, and EPS decreased by -4.55% YoY to $0.21. However, gross margin improved by 14.03% YoY to 44.39%.
Goldman Sachs analysts removed a related company from their APAC Conviction List, which may signal a cautious outlook. No direct analyst upgrades or downgrades for NMR were noted.
